Literature DB >> 20378180

Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.

Luiz H Lima1, Carl Schubert, Daniela C Ferrara, Joanna E Merriam, Yutaka Imamura, K Bailey Freund, Richard F Spaide, Lawrence A Yannuzzi, Rando Allikmets.   

Abstract

PURPOSE: To investigate the frequency of variants in 3 major age-related macular degeneration (AMD)-associated loci in patients of European-American descent with polypoidal choroidal vasculopathy (PCV).
DESIGN: Cross-sectional, case-control association study. PARTICIPANTS: Fifty-five patients with PCV, 368 patients with advanced AMD, and 368 age-matched and ethnically matched unaffected controls of European-American descent.
METHODS: Association analysis of allele and genotype frequencies, determined by TaqMan assays, was performed for the following haplotype-tagging single nucleotide polymorphisms (htSNPs): risk alleles in the complement factor H (CFH) gene (Y402H and IVS14) in the ARMS2/HTRA1 locus on 10q26 (A69S) and protective alleles in CFH (IVS1 and IVS6) and in the complement factor B/complement component C2 (CFB/C2) locus (IVS10 and H9L). MAIN OUTCOME MEASURES: Allele and genotype frequencies of the htSNPs in the CFH, CFB/C2, and ARMS2/HTRA1 loci.
RESULTS: Four AMD-associated haplotype-tagging alleles (rs547154, rs1061170, rs1410996, rs10490924) in the 3 major loci, CFH, CFB/C2, and ARMS2/HTRA1, also were statistically significantly associated with the PCV phenotype (P<0.05). Three other alleles from the same loci (rs4151667, rs529825, rs3766404) showed a trend toward association (P<0.2) but did not reach statistical significance, possibly because of the combined effects of a relatively small sample size and low minor allele frequency in the screened populations.
CONCLUSIONS: The PCV phenotype in Caucasian patients is associated with the major alleles/genotypes in the AMD-associated loci, suggesting that PCV and AMD are genetically similar in the tested loci. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378180      PMCID: PMC2901561          DOI: 10.1016/j.ophtha.2009.12.018

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

1.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

2.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.

Authors:  L A Yannuzzi; D W Wong; B S Sforzolini; M Goldbaum; K C Tang; R F Spaide; K B Freund; J S Slakter; D R Guyer; J A Sorenson; Y Fisher; D Maberley; D A Orlock
Journal:  Arch Ophthalmol       Date:  1999-11

3.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

4.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

5.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.

Authors:  Kenichiro Sho; Kanji Takahashi; Haruhiko Yamada; Mitsumasa Wada; Yoshimi Nagai; Tsuyoshi Otsuji; Maki Nishikawa; Yumiko Mitsuma; Yukari Yamazaki; Miyo Matsumura; Masanobu Uyama
Journal:  Arch Ophthalmol       Date:  2003-10

6.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

Authors:  Sung Chul Lee; Youl Seok Seong; Sung Soo Kim; Hyung Jun Koh; Oh Woong Kwon
Journal:  Ophthalmologica       Date:  2004 May-Jun       Impact factor: 3.250

7.  Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

Authors:  Richard F Spaide; Irene Donsoff; Deborah L Lam; Lawrence A Yannuzzi; Lee M Jampol; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

8.  ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Norimoto Gotoh; Hideo Nakanishi; Hisako Hayashi; Ryo Yamada; Atsushi Otani; Akitaka Tsujikawa; Kenji Yamashiro; Hiroshi Tamura; Masaaki Saito; Kuniharu Saito; Tomohiro Iida; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2009-03-09       Impact factor: 5.258

9.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

10.  Morphologic and angiographic assessment of the macula after macular translocation surgery with 360 degrees retinotomy.

Authors:  Hiroko Terasaki; Kohei Ishikawa; Toshimitsu Suzuki; Makoto Nakamura; Kensaku Miyake; Yozo Miyake
Journal:  Ophthalmology       Date:  2003-12       Impact factor: 12.079

View more
  36 in total

1.  Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2011-09-29       Impact factor: 2.447

2.  Development of polypoidal lesions in age-related macular degeneration.

Authors:  A Tsujikawa; Y Ojima; K Yamashiro; S Ooto; H Tamura; I Nakata; N Yoshimura
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

3.  Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population.

Authors:  L Huang; Q Meng; C Zhang; Y Sun; Y Bai; S Li; X Deng; B Wang; W Yu; M Zhao; X Li
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

4.  Early-onset stroke and vasculopathy associated with mutations in ADA2.

Authors:  Qing Zhou; Dan Yang; Amanda K Ombrello; Andrey V Zavialov; Camilo Toro; Anton V Zavialov; Deborah L Stone; Jae Jin Chae; Sergio D Rosenzweig; Kevin Bishop; Karyl S Barron; Hye Sun Kuehn; Patrycja Hoffmann; Alejandra Negro; Wanxia L Tsai; Edward W Cowen; Wuhong Pei; Joshua D Milner; Christopher Silvin; Theo Heller; David T Chin; Nicholas J Patronas; John S Barber; Chyi-Chia R Lee; Geryl M Wood; Alexander Ling; Susan J Kelly; David E Kleiner; James C Mullikin; Nancy J Ganson; Heidi H Kong; Sophie Hambleton; Fabio Candotti; Martha M Quezado; Katherine R Calvo; Hawwa Alao; Beverly K Barham; Anne Jones; James F Meschia; Bradford B Worrall; Scott E Kasner; Stephen S Rich; Raphaela Goldbach-Mansky; Mario Abinun; Elizabeth Chalom; Alisa C Gotte; Marilynn Punaro; Virginia Pascual; James W Verbsky; Troy R Torgerson; Nora G Singer; Timothy R Gershon; Seza Ozen; Omer Karadag; Thomas A Fleisher; Elaine F Remmers; Shawn M Burgess; Susan L Moir; Massimo Gadina; Raman Sood; Michael S Hershfield; Manfred Boehm; Daniel L Kastner; Ivona Aksentijevich
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

5.  One-year results of intravitreal conbercept in treatment-naïve subjects with polypoidal choroidal vasculopathy.

Authors:  Lin-Hong Ye; Yi Cai; Xuan Shi; Ian Yat Hin Wong; Jin-Feng Qu; Ming-Wei Zhao; Xin Ying; Xiao-Xin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-04       Impact factor: 3.117

6.  Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Authors:  Sandeep Kumar; Hiroyuki Nakashizuka; Alex Jones; Alyssia Lambert; Xuchen Zhao; Megan Shen; Mackenzie Parker; Shixian Wang; Zachary Berriochoa; Amrita Fnu; Stephanie VanBeuge; Patricia Chévez-Barrios; Mark Tso; Jon Rainier; Yingbin Fu
Journal:  Am J Pathol       Date:  2017-09-21       Impact factor: 4.307

7.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

Review 8.  [Personalized molecular medicine: new paradigms in the treatment of cochlear implant and cancer patients].

Authors:  H P Zenner; M Pfister; N Friese; E Zrenner; M Röcken
Journal:  HNO       Date:  2014-07       Impact factor: 1.284

9.  Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.

Authors:  T Toyama; K Ohtomo; Y Noda; T Ueta
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

10.  COL8A1 rs13095226 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in Chinese subjects.

Authors:  Yang Yu; Lvzhen Huang; Bin Wang; Chunfang Zhang; Yujing Bai; Xiaoxin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.